Surgical Management of Lipodystrophy in Barraquer-Simons Syndrome: Autologous Fat Redistribution and Reconstructive Strategies for Acquired Partial Lipodystrophy
Main Article Content
Abstract
Background: Barraquer-Simons Syndrome (BSS), a rare form of acquired partial lipodystrophy, is characterized by progressive adipose tissue loss in the cephalothoracic region, often with paradoxical fat accumulation in the lower body. This condition presents significant metabolic and aesthetic challenges, necessitating multidisciplinary management. Fat redistribution surgery (FRS) has emerged as a potential therapeutic approach to restore facial and upper body contour while addressing metabolic complications.
Objective: This article reviews the surgical techniques, outcomes, and long-term efficacy of autologous fat grafting and liposuction-based fat redistribution in BSS patients, with a focus on optimizing functional and cosmetic results.
Methods: A comprehensive literature review was conducted, analyzing case reports, clinical studies, and surgical outcomes in BSS patients undergoing fat redistribution procedures. Special emphasis was placed on patient selection, surgical planning, and postoperative metabolic implications.
Results: Preliminary evidence suggests that autologous fat transfer from areas of lipohypertrophy (e.g., lower extremities) to atrophic regions (e.g., face, arms, and trunk) can improve both aesthetic and psychosocial outcomes. However, long-term fat graft retention remains variable, and metabolic stability post-surgery requires further investigation.
Conclusion: Fat redistribution surgery offers a promising reconstructive option for BSS patients, though individualized surgical planning and close metabolic monitoring are essential. Further prospective studies are needed to standardize techniques and assess durability.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Garg A. Lipodystrophies: genetic and acquired body fat disorders. J Clin Endocrinol Metab 2011;96:3313–25. 10.1210/jc.2011-1159
II. Garg A. Acquired and inherited lipodystrophies. N Engl J Med 2004;350:1220–34.
III. 0.1056/NEJMra025261
IV. Simsek-Kiper PO, Roach E, Utine GE et al. Barraquer-Simons syndrome: a rare clinical entity. Am J Med Genet A 2014;164A:1756–60. 10.1002/ajmg.a.36491
V. Misra A, Peethambaram A, Garg A. Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature. Medicine (Baltimore) 2004;83:18–34. 10.1097/01.md.0000111061.69212.59
VI. Capeau J, Magré J, Caron-Debarle M et al. Human lipodystrophies: genetic and acquired diseases of adipose tissue. Endocr Dev 2010;19:1–20. 10.1159/000316893
VII. Coleman SR. Facial recontouring with lipostructure. Clin Plast Surg 1997;24:347–67.
VIII. Szczerkowska-Dobosz A, Olszewska B, Lemańska M et al. Acquired facial lipoatrophy: pathogenesis and therapeutic options. Postepy Dermatol Alergol 2015;32:127–33. 10.5114/pdia.2014.40971
IX. Guaraldi G, Murri R, Orlando G et al. Severity of lipodystrophy is associated with decreased health-related quality of life. AIDS Patient Care STDS 2008;22:577–85. 10.1089/apc.2007.0173
X. Leclercq P, Goujard C, Duracinsky M et al. High prevalence and impact on the quality of life of facial lipoatrophy and other abnormalities in fat tissue distribution in HIV-infected patients treated with antiretroviral therapy. AIDS Res Hum Retroviruses 2013;29:761–8. 10.1089/aid.2012.0214
XI. Verolet CM, Delhumeau-Cartier C, Sartori M et al. Lipodystrophy among HIV-infected patients: a cross-sectional study on impact on quality of life and mental health disorders. AIDS Res Ther 2015;12:21 10.1186/s12981-015-0061-z
XII. Raposo-Amaral CE, Denadai R, Camargo DN et al. Parry-Romberg syndrome: severity of the deformity does not correlate with quality of life. Aesthetic Plast Surg 2013;37:792–801. 10.1007/s00266-013-0142-0
XIII. Winters R, Moulthrop T. Is autologous fat grafting superior to other fillers for facial rejuvenation? Laryngoscope 2013;123:1068–9.
1002/lary.23614
XIV. Ducours JL, Poizac P, Ardanza B et al. Barraquer-Simons syndrome and facial lipo-filling. Apropos of a case. Rev Stomatol Chir Maxillofac 1991;92:105–11.
XV. Jagdeo J, Ho D, Lo A et al. A systematic review of filler agents for aesthetic treatment of HIV facial lipoatrophy (FLA). J Am Acad Dermatol 2015;73:1040–54. 10.1016/j.jaad.2015.08.040
XVI. Rauso R, Curinga G, Santillo V et al. Comparison between lipofilling and a nonabsorbable filler for facial wasting rehabilitation in HIV-positive patients. J Craniofac Surg 2011;22:1684–8. 10.1097/SCS.0b013e31822e5cf8